ASND

Conviction 80HealthcareScan · Mon, Aug 10, 2026

ASND$255.58+0.07%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 571K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Ascendis Pharma A/SBiotechnologywww.ascendispharma.com ↗

Price255.58

Change+0.07%

Gap+0.36%

Rel volume2.86×

Avg volume558.55K

Avg $ vol141.45M

SMA 20253.42

SMA 50245.51

SMA 200227.49

Price vs 50+4.10%

Price vs 200+12.35%

MA stackbullish

50/200 cross—

Supertrenddown · 266.64

RSI (14)54

MACD hist-0.46

MACD cross—

Stoch %K / %D78 / 66

ADX (14)15

+DI / −DI20 / 19

RSI divergence—

MACD divergence—

ATR %+3.19%

ADR %2.95%

52w high277.18

52w low189.74

From 52w high-7.79%

Above 52w low+34.70%

New 52w highNo

SqueezeOff

Bollinger width10.39%

%B0.58

Donchian pos54.84%

Donchian high268.77

Donchian low239.56

AVWAP (52w high)255.87

vs AVWAP high-0.11%

AVWAP (52w low)223.99

vs AVWAP low+14.10%

OBV trendUp

Chaikin MF (20)-0.11

Today vs 20d2.86×

Avg vol (14d)571K

Avg vol (20d)558.55K

Avg $ vol (20d)141.45M

Market cap—

RS 3m (vs SPY)-1.93%

RS 6m (vs SPY)+3.38%

RS line new highNo

Trend template7/8

Technical rank66.6

1 week+4.98%

1 month-5.50%

3 months+7.09%

6 months+15.05%

1 year+34.27%

YTD+19.83%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional103.51%

Ent. value15.84B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out—

Employees1.19K

ListedMon, Apr 20, 2026

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank66.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance278.52

Support231.19

Days since event—

Candle confirm—

News sentiment—

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Broke out
Jun 26 – Jul 1
4 scans
→
Setting up
Jul 15
1 scan

Congress activity

Disclosed STOCK Act trades in ASND

All disclosures →

No recent disclosed trades by Congress in ASND. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ASND · 5 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
SMITH SCOTT THOMAS EVP & Chief Financial Officer · Ordinary Shares · 2026-06-02	Buy	100	$22K	2026-06-02	2026-06-02
BIENAIME JEAN JACQUES Director · Ordinary Shares · 2026-05-29	Buy	100	$22K	2026-05-29	2026-06-01
BIENAIME JEAN JACQUES Director · Ordinary Shares · 2026-05-29	Buy	200	$44K	2026-05-29	2026-06-01
SMITH SCOTT THOMAS EVP & Chief Financial Officer · Ordinary Shares · 2026-05-29	Buy	250	$56K	2026-05-29	2026-06-01
BIENAIME JEAN JACQUES Director · Ordinary Shares · 2026-05-26	Buy	200	$48K	2026-05-26	2026-05-27
JENSEN FLEMMING STEEN See Remarks · Ordinary Shares · 2026-05-11	Sell	19.46K	$4.6M	2026-05-11	2026-05-12

SEC filings

EDGAR filings in ASND · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.